Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
- PMID: 33052972
- PMCID: PMC7556447
- DOI: 10.1371/journal.pone.0240965
Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Expression of concern for
-
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.PLoS One. 2020 Sep 25;15(9):e0239799. doi: 10.1371/journal.pone.0239799. eCollection 2020. PLoS One. 2020. Retraction in: PLoS One. 2024 Jun 6;19(6):e0305303. doi: 10.1371/journal.pone.0305303. PMID: 32976513 Free PMC article. Retracted.
References
-
- Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, et al. (2020) Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS ONE 15(9): e0239799 10.1371/journal.pone.0239799 - DOI - PMC - PubMed
-
- Talebpour M, Hadadi A, Oraii A, Ashraf H. Rationale and Design of a Registry in a Referral and Educational Medical Center in Tehran, Iran: Sina Hospital Covid-19 Registry (SHCo-19R). Adv J Emerg Med. 4(2s):e53.
Publication types
LinkOut - more resources
Full Text Sources
